People
Katherine High, the longtime head of research and development at Spark Therapeutics, is stepping down from the company as it prepares to be absorbed by Swiss pharma giant Roche.
Biopharma and life sciences companies strengthen their leadership teams and board with this week’s Movers & Shakers.
Kazia Therapeutics is company focused on developing anti-cancer drugs.
A group of unions and consumer organizations have banded together in opposition to the $63 billion merger citing concerns that it will create a monopoly and harm competition.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Virginia, which is part of the BioSpace Hotbed region known as BioCapital, is home to an $8 billion biopharma market that employs more than 26,545 people.
Hector Armando Kellum, a former senior executive with the Novartis subsidiary Sandoz, pleaded guilty for his role in a price-fixing scheme for generic drugs developed by his company.
It is planned to go into operation in 2021, and is expected to create more than 200 new jobs in Lee County, North Carolina.
Frank Reynolds, the founder and chief executive officer of PixarBio, was also ordered to repay $7.5 million to investors who backed the company’s non-opioid painkiller, NeuroRelease.
Dr. Bopp is a pioneer in understanding the impact of the acidic tumour microenvironment on local immune cell function
PRESS RELEASES